We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+8.38%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$3.84B
AUM Growth
-$2.1B
Cap. Flow
-$2.45B
Cap. Flow %
-63.69%
Top 10 Hldgs %
22.61%
Holding
6,382
New
824
Increased
1,880
Reduced
2,765
Closed
701

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$120M
2
MSFT icon
Microsoft
MSFT
+$115M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$72.4M
4
AMZN icon
Amazon
AMZN
+$69.8M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$51.2M

Sector Composition

Rank Sector Weight
1 Technology 19.05%
2 Consumer Discretionary 11.67%
3 Healthcare 9.59%
4 Financials 9.24%
5 Communication Services 7.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHD icon
1551
Church & Dwight Co
CHD
$24.5B
$319K 0.01%
3,743
-12,951
-78% -$1.12M
HGV icon
1552
Hilton Grand Vacations
HGV
$3.55B
$319K 0.01%
7,724
+377
+5% +$16.4K
PINC
1553
DELISTED
Premier
PINC
$319K 0.01%
9,180
+8,766
+2,117% +$303K
CVLT icon
1554
Commault Systems
CVLT
$5.61B
$318K 0.01%
4,070
-807
-17% -$58.7K
IAK icon
1555
iShares US Insurance ETF
IAK
$540M
$318K 0.01%
+4,110
New +$324K
CAH icon
1556
Cardinal Health
CAH
$55.4B
$317K 0.01%
5,565
-32,522
-85% -$1.9M
DINO icon
1557
HF Sinclair
DINO
$14.5B
$317K 0.01%
9,649
-19,364
-67% -$673K
HAE icon
1558
Haemonetics
HAE
$4B
$317K 0.01%
4,761
-7,920
-62% -$560K
SJNK icon
1559
State Street SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
$4.76B
$317K 0.01%
+11,499
New +$315K
ACLS icon
1560
Axcelis
ACLS
$4.33B
$316K 0.01%
7,808
+5,353
+218% +$222K
AZN icon
1561
AstraZeneca
AZN
$250B
$316K 0.01%
2,634
-8,034
-75% -$881K
EGHT icon
1562
8x8 Inc
EGHT
$332M
$316K 0.01%
11,387
+3,036
+36% +$86.1K
NVAX icon
1563
Novavax
NVAX
$1.31B
$316K 0.01%
1,486
-4,426
-75% -$811K
BHF icon
1564
Brighthouse Financial
BHF
$3.5B
$315K 0.01%
6,936
+2,094
+43% +$98.4K
CPB icon
1565
Campbell Soup
CPB
$6.87B
$315K 0.01%
6,898
-10,610
-61% -$511K
IBN icon
1566
ICICI Bank
IBN
$108B
$315K 0.01%
18,422
-10,539
-36% -$175K
MZZ icon
1567
ProShares UltraShort MidCap400
MZZ
$2.34M
$315K 0.01%
17,574
-6,537
-27% -$118K
QDEL icon
1568
QuidelOrtho
QDEL
$838M
$315K 0.01%
2,455
-2,348
-49% -$276K
CYTK icon
1569
Cytokinetics
CYTK
$10.4B
$314K 0.01%
15,903
+9,217
+138% +$216K
ULTA icon
1570
Ulta Beauty
ULTA
$24.3B
$314K 0.01%
909
-3,410
-79% -$1.12M
FLO icon
1571
Flowers Foods
FLO
$1.57B
$313K 0.01%
12,927
+1,080
+9% +$26.2K
HMN icon
1572
Horace Mann Educators
HMN
$2.11B
$313K 0.01%
8,350
+4,919
+143% +$196K
CELL
1573
DELISTED
PhenomeX Inc. Common Stock
CELL
$313K 0.01%
6,986
-10,104
-59% -$468K
KWR icon
1574
Quaker Houghton
KWR
$2.92B
$312K 0.01%
1,317
+228
+21% +$54.5K
SLGN icon
1575
Silgan Holdings
SLGN
$4.41B
$312K 0.01%
7,507
+542
+8% +$23K

Similar funds

Tower Research Capital (TRC)'s Q2 2021 Portfolio in Review

As of Q2 2021, Tower Research Capital (TRC) held 6,382 positions worth $3.84B, down 35% from $5.94B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Tower Research Capital (TRC) withdrew a net $2.45B in Q2 2021, closing 701 positions and reducing 2,765 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $15.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Invesco NASDAQ Biotechnology ETF worth $8.44M.

  • Tower Research Capital (TRC)'s largest Q2 2021 buy was Invesco NASDAQ Biotechnology ETF: 325,629 shares worth $8.44M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $175M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2021 reduction was Apple, cutting an estimated $120M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 Growth ETF in Q2 2021, selling an estimated $15.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 23% of its $3.84B portfolio in Q2 2021.
  • Tower Research Capital (TRC) opened 824 new positions and closed 701 in Q2 2021.
  • Tower Research Capital (TRC)'s portfolio value fell 35% quarter-over-quarter to $3.84B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2021, filed 16 Aug 2021.